Ian Loke

1.4k total citations
19 papers, 847 citations indexed

About

Ian Loke is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, Ian Loke has authored 19 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cardiology and Cardiovascular Medicine, 6 papers in Pulmonary and Respiratory Medicine and 5 papers in Epidemiology. Recurrent topics in Ian Loke's work include Heart Failure Treatment and Management (7 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers) and Cardiac pacing and defibrillation studies (2 papers). Ian Loke is often cited by papers focused on Heart Failure Treatment and Management (7 papers), Cardiovascular, Neuropeptides, and Oxidative Stress Research (2 papers) and Cardiac pacing and defibrillation studies (2 papers). Ian Loke collaborates with scholars based in United Kingdom, Thailand and United States. Ian Loke's co-authors include Leong L. Ng, Joan E. Davies, Iain Squire, Russell J. O’Brien, Sanjay Bhandari, Joachim Struck, Derek Chin, R O'Brien, B. Pathik and Margaret Stone and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Ian Loke

15 papers receiving 826 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ian Loke United Kingdom 12 557 232 189 125 113 19 847
Frank Muders Germany 15 748 1.3× 180 0.8× 110 0.6× 36 0.3× 114 1.0× 34 988
Cezar Macarie Romania 16 747 1.3× 208 0.9× 142 0.8× 14 0.1× 63 0.6× 30 1.0k
Yoram Shenker United States 17 653 1.2× 222 1.0× 200 1.1× 21 0.2× 339 3.0× 40 1.2k
Takashi Nakagawa Japan 15 306 0.5× 106 0.5× 80 0.4× 20 0.2× 49 0.4× 54 673
J Preibisz United States 11 366 0.7× 279 1.2× 155 0.8× 22 0.2× 67 0.6× 19 716
Christoph Birner Germany 18 524 0.9× 110 0.5× 123 0.7× 26 0.2× 59 0.5× 57 890
Christos A. Goudis Greece 16 791 1.4× 156 0.7× 92 0.5× 33 0.3× 52 0.5× 29 1.0k
Christopher R. Gibbs United Kingdom 14 555 1.0× 93 0.4× 102 0.5× 22 0.2× 60 0.5× 20 768
Michael Resl Austria 15 462 0.8× 54 0.2× 78 0.4× 22 0.2× 219 1.9× 53 885
Athanasios Trikas Greece 16 535 1.0× 76 0.3× 137 0.7× 8 0.1× 48 0.4× 50 782

Countries citing papers authored by Ian Loke

Since Specialization
Citations

This map shows the geographic impact of Ian Loke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Loke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Loke more than expected).

Fields of papers citing papers by Ian Loke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian Loke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Loke. The network helps show where Ian Loke may publish in the future.

Co-authorship network of co-authors of Ian Loke

This figure shows the co-authorship network connecting the top 25 collaborators of Ian Loke. A scholar is included among the top collaborators of Ian Loke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian Loke. Ian Loke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Loke, Ian, et al.. (2024). Carcinoid Heart Disease Associated with Primary Ovarian Carcinoid Tumor: A Rare Presentation. SHILAP Revista de lepidopterología. 25(2). 106–109.
3.
Cowie, Martín, Andrew Flett, Peter J. Cowburn, et al.. (2021). Real-World Evidence in a National Health Service: Results of the UK CardioMEMS HF System Post-Market Study. ESC Heart Failure. 9(1). 48–56. 32 indexed citations
4.
Loke, Ian, et al.. (2019). Separation anxiety: Extreme dehiscence of a mitral annuloplasty ring. Echocardiography. 36(6). 1219–1221.
5.
Gulsin, Gaurav S., et al.. (2016). Takotsubo cardiomyopathy with left ventricular thrombus presenting as critical limb ischaemia. Oxford Medical Case Reports. 2016(8). omw051–omw051. 1 indexed citations
6.
Evans, Rachael A, Sally Singh, R. Collier, et al.. (2010). Generic, symptom based, exercise rehabilitation; integrating patients with COPD and heart failure. Respiratory Medicine. 104(10). 1473–1481. 54 indexed citations
7.
Arthur, Scott, et al.. (2009). Hypothyroidism presenting with recurrent pericardial tamponade: Figure 1. BMJ Case Reports. 2009. bcr0320091674–bcr0320091674. 6 indexed citations
8.
Jutley, Rajwinder S., David Waller, Ian Loke, et al.. (2008). Video‐Assisted Thoracoscopic Implantation of the Left Ventricular Pacing Lead for Cardiac Resynchronization Therapy. Pacing and Clinical Electrophysiology. 31(7). 812–818. 31 indexed citations
9.
Bhandari, Sanjay, et al.. (2008). Gender and renal function influence plasma levels of copeptin in healthy individuals. Clinical Science. 116(3). 257–263. 132 indexed citations
10.
Loke, Ian, et al.. (2007). Cardioverter-defibrillator box damage secondary to lead insulation defect. EP Europace. 9(7). 544–544.
11.
Ng, Leong L., B. Pathik, Ian Loke, Iain Squire, & Joan E. Davies. (2006). Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure. American Heart Journal. 152(1). 94–101. 74 indexed citations
12.
Vlachou, Paraskevi A., Ian Loke, Derek Chin, et al.. (2006). Bilateral Sinus of Valsalva Aneurysms. Circulation. 114(16). e542–3. 1 indexed citations
13.
Ng, Leong L., Ian Loke, Joan E. Davies, et al.. (2005). Community screening for left ventricular systolic dysfunction using plasma and urinary natriuretic peptides. Journal of the American College of Cardiology. 45(7). 1043–1050. 72 indexed citations
14.
Ng, Leong L., et al.. (2004). Diagnosis of heart failure using urinary natriuretic peptides. Clinical Science. 106(2). 129–133. 75 indexed citations
15.
Ng, Leong L., Ian Loke, Russell J. O’Brien, Iain Squire, & Joan E. Davies. (2004). Plasma urocortin in human systolic heart failure. Clinical Science. 106(4). 383–388. 70 indexed citations
16.
O’Brien, Russell J., Ian Loke, Joan E. Davies, Iain Squire, & Leong L. Ng. (2003). Myotrophin in human heart failure. Journal of the American College of Cardiology. 42(4). 719–725. 21 indexed citations
17.
Loke, Ian, Iain Squire, Joan E. Davies, & Leong L. Ng. (2003). Reference Ranges for Natriuretic Peptides for Diagnostic Use are Dependent on Age, Gender and Heart Rate. European Journal of Heart Failure. 5(5). 599–606. 105 indexed citations
18.
Ng, Leong L., Ian Loke, Joan E. Davies, et al.. (2003). Identification of Previously Undiagnosed Left Ventricular Systolic Dysfunction: Community Screening Using Natriuretic Peptides and Electrocardiography. European Journal of Heart Failure. 5(6). 775–782. 41 indexed citations
19.
Ng, Leong L., Ian Loke, Russell J. O’Brien, Iain Squire, & Joan E. Davies. (2002). Plasma Urotensin in Human Systolic Heart Failure. Circulation. 106(23). 2877–2880. 132 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026